Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1L80
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,476
Award facts
- Contract value 100% obligated
- $15,476.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $15,476.15 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen (2 mL) on December 2, 2025, with a completion date of December 3, 2025. This is a firm fixed price, non-competitive set-aside contract supporting federal medical procurement needs. The award is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran healthcare systems.
The underlying IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Dupixent (dupilumab) is a monoclonal antibody used to treat moderate-to-severe atopic dermatitis and other allergic and inflammatory conditions, making this delivery order part of the company's extensive portfolio of specialty medications and brand-name pharmaceuticals supplied through DLA's medical supply chain. The DLA Troop Support Medical contract demonstrates AmerisourceBergen's capability to fulfill federal procurement requirements and serve customers including the Defense Health Agency and U.S. Coast Guard through flexible and comprehensive contracting vehicles.
Quick answers
Who was awarded contract SPE2DR26F1L80?
SPE2DR26F1L80 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F1L80 worth?
The government has obligated $15,476 on SPE2DR26F1L80.
Is contract SPE2DR26F1L80 an order under another contract?
Yes. SPE2DR26F1L80 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1L80 competed?
The extent of competition for SPE2DR26F1L80 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award